Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cusan

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
International Journal of Fertility|January 1, 1980
Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in manF Labrie, L Cusan, C Séguin, et al.
The Prostate|February 11, 1999
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trialF Labrie, B Candas, A Dupont, et al.
Journal of Steroid Biochemistry|October 1, 1989
Combination therapy with castration and flutamide: today's treatment of choice for prostate cancerF Labrie, A Dupont, L Cusan, et al.
The Prostate|August 29, 2000
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancerB Candas, L Cusan, J L Gomez, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trialF Labrie, A Dupont, L Cusan, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and functionF Labrie, C Auclair, L Cusan, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigenF Labrie, A Dupont, R Suburu, et al.
Maturitas|October 1, 1991
Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal womenA Dupont, P Dupont, L Cusan, et al.
Journal of Steroid Biochemistry|January 1, 1988
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choiceF Labrie, A Dupont, L Cusan, et al.
Urology|March 1, 1997
Neoadjuvant hormonal therapy: the Canadian experienceF Labrie, L Cusan, J L Gomez, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
International Journal of Fertility|January 1, 1980
Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in manF Labrie, L Cusan, C Séguin, et al.
The Prostate|February 11, 1999
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trialF Labrie, B Candas, A Dupont, et al.
Journal of Steroid Biochemistry|October 1, 1989
Combination therapy with castration and flutamide: today's treatment of choice for prostate cancerF Labrie, A Dupont, L Cusan, et al.
The Prostate|August 29, 2000
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancerB Candas, L Cusan, J L Gomez, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trialF Labrie, A Dupont, L Cusan, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Inhibitory effects of treatment with LHRH or its agonists on ovarian receptor levels and functionF Labrie, C Auclair, L Cusan, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigenF Labrie, A Dupont, R Suburu, et al.
Maturitas|October 1, 1991
Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal womenA Dupont, P Dupont, L Cusan, et al.
Journal of Steroid Biochemistry|January 1, 1988
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: today's therapy of choiceF Labrie, A Dupont, L Cusan, et al.
Urology|March 1, 1997
Neoadjuvant hormonal therapy: the Canadian experienceF Labrie, L Cusan, J L Gomez, et al.
Pageof 10